Symbol:
Pygm
Name:
glycogen phosphorylase, muscle associated
RGD ID:
3461
Description:
Enables carbohydrate binding activity; glycogen phosphorylase activity; and heterocyclic compound binding activity. Involved in several processes, including glycogen catabolic process; response to cAMP; and response to hypoxia. Located in sarcoplasmic reticulum. Used to study cholestasis. Human ortholog(s) of this gene implicated in glycogen storage disease V. Orthologous to human PYGM (glycogen phosphorylase, muscle associated); PARTICIPATES IN glycogen degradation pathway; insulin signaling pathway; starch and sucrose metabolic pathway; INTERACTS WITH (R)-noradrenaline; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
glycogen phosphorylase, muscle form; muscle (McArdle syndrome); muscle glycogen phosphorylase; Muscpho; myophosphorylase; Phosphorylase glycogen; Phosphorylase, glycogen; phosphorylase, glycogen, muscle
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
PYGM (glycogen phosphorylase, muscle associated)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Pygm (muscle glycogen phosphorylase)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Pygm (glycogen phosphorylase, muscle associated)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
PYGM (glycogen phosphorylase, muscle associated)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
PYGM (glycogen phosphorylase, muscle associated)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Pygm (glycogen phosphorylase, muscle associated)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
PYGM (glycogen phosphorylase, muscle associated)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
PYGM (glycogen phosphorylase, muscle associated)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Pygm (glycogen phosphorylase, muscle associated)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
PYGB (glycogen phosphorylase B)
HGNC
OrthoDB
Alliance orthologs 3
Homo sapiens (human):
PYGM (glycogen phosphorylase, muscle associated)
Alliance
DIOPT (HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Pygm (muscle glycogen phosphorylase)
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
pygma (phosphorylase, glycogen, muscle A)
Alliance
DIOPT (InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Danio rerio (zebrafish):
pygmb (phosphorylase, glycogen, muscle b)
Alliance
DIOPT (InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Saccharomyces cerevisiae (baker's yeast):
GPH1
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
GlyP
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
pygl-1
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 213,119,805 - 213,134,622 (+) NCBI GRCr8 mRatBN7.2 1 203,690,550 - 203,705,369 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 203,690,533 - 203,705,368 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 212,039,387 - 212,054,202 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 219,135,880 - 219,150,695 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 211,826,933 - 211,841,748 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 221,756,325 - 221,771,142 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 221,756,286 - 221,771,143 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 228,737,461 - 228,758,937 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 209,166,701 - 209,181,588 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 209,325,179 - 209,340,017 (+) NCBI Celera 1 201,223,967 - 201,238,784 (+) NCBI Celera Cytogenetic Map 1 q43 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Pygm Rat (-)-epigallocatechin 3-gallate multiple interactions ISO PYGM (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PYGM mRNA CTD PMID:22079256 Pygm Rat (R)-noradrenaline affects expression EXP 6480464 Norepinephrine affects the expression of PYGM mRNA CTD PMID:14618266 Pygm Rat 17alpha-ethynylestradiol affects expression ISO Pygm (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of PYGM mRNA CTD PMID:17555576 Pygm Rat 17alpha-ethynylestradiol increases expression ISO Pygm (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of PYGM mRNA CTD PMID:17942748 Pygm Rat 17alpha-ethynylestradiol multiple interactions ISO Pygm (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PYGM mRNA CTD PMID:17942748 Pygm Rat 17beta-estradiol decreases expression ISO Pygm (Mus musculus) 6480464 Estradiol results in decreased expression of PYGM mRNA CTD PMID:19484750 Pygm Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PYGM mRNA CTD PMID:32145629 Pygm Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO PYGM (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Pygm Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Pygm (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PYGM mRNA CTD PMID:17942748 Pygm Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PYGM mRNA CTD PMID:32109520 Pygm Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Pygm (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PYGM mRNA CTD PMID:21570461 Pygm Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Pygm (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of PYGM mRNA CTD PMID:17942748 Pygm Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Pygm Rat 2,4,6-tribromophenol increases expression ISO PYGM (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 Pygm Rat 2,5-hexanedione decreases expression EXP 6480464 2 and 5-hexanedione results in decreased expression of PYGM protein CTD PMID:19033394 Pygm Rat 3,3',5,5'-tetrabromobisphenol A increases expression ISO PYGM (Homo sapiens) 6480464 tetrabromobisphenol A results in increased expression of PYGM protein CTD PMID:31675489 Pygm Rat 4,4'-sulfonyldiphenol increases expression ISO Pygm (Mus musculus) 6480464 bisphenol S results in increased expression of PYGM mRNA CTD PMID:30951980 Pygm Rat 4,4'-sulfonyldiphenol affects methylation ISO Pygm (Mus musculus) 6480464 bisphenol S affects the methylation of PYGM gene CTD PMID:31683443 Pygm Rat 4-hydroxyphenyl retinamide decreases expression ISO Pygm (Mus musculus) 6480464 Fenretinide results in decreased expression of PYGM mRNA CTD PMID:16467112 Pygm Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PYGM mRNA CTD PMID:24780913 Pygm Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of PYGM mRNA CTD PMID:31881176 Pygm Rat acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of PYGM mRNA CTD PMID:28959563 Pygm Rat aflatoxin B1 increases methylation ISO PYGM (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of PYGM exon CTD PMID:30157460 Pygm Rat alpha-Zearalanol decreases expression EXP 6480464 Zeranol results in decreased expression of PYGM mRNA CTD PMID:35163327 Pygm Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PYGM mRNA CTD PMID:35163327 Pygm Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PYGM mRNA CTD PMID:16483693 Pygm Rat aristolochic acid A increases expression ISO PYGM (Homo sapiens) 6480464 aristolochic acid I results in increased expression of PYGM mRNA CTD PMID:33212167 Pygm Rat arsenite(3-) decreases expression ISO Pygm (Mus musculus) 6480464 arsenite results in decreased expression of PYGM mRNA CTD PMID:33053406 Pygm Rat astemizole increases expression EXP 6480464 Astemizole results in increased expression of PYGM mRNA CTD PMID:20221588 Pygm Rat benzo[a]pyrene decreases expression ISO Pygm (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of PYGM mRNA CTD PMID:22228805 Pygm Rat benzo[a]pyrene increases expression ISO Pygm (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of PYGM mRNA CTD PMID:32417428 Pygm Rat benzo[a]pyrene decreases expression ISO PYGM (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of PYGM mRNA CTD PMID:22316170 Pygm Rat bis(2-ethylhexyl) phthalate increases expression ISO Pygm (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of PYGM mRNA CTD PMID:28085963 Pygm Rat bis(2-ethylhexyl) phthalate decreases expression ISO PYGM (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of PYGM mRNA CTD PMID:31163220 Pygm Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PYGM mRNA CTD PMID:25181051 and PMID:32145629 Pygm Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PYGM mRNA CTD PMID:38750585 Pygm Rat bisphenol A increases expression ISO PYGM (Homo sapiens) 6480464 bisphenol A results in increased expression of PYGM protein CTD PMID:37567409 Pygm Rat bisphenol A decreases expression ISO PYGM (Homo sapiens) 6480464 bisphenol A results in decreased expression of PYGM protein CTD PMID:31675489 Pygm Rat bisphenol A increases expression ISO Pygm (Mus musculus) 6480464 bisphenol A results in increased expression of PYGM mRNA CTD PMID:30951980 Pygm Rat bisphenol AF increases expression ISO PYGM (Homo sapiens) 6480464 bisphenol AF results in increased expression of PYGM protein CTD PMID:34186270 Pygm Rat bisphenol F increases expression ISO Pygm (Mus musculus) 6480464 bisphenol F results in increased expression of PYGM mRNA CTD PMID:30951980 and PMID:38685157 Pygm Rat bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of PYGM mRNA CTD PMID:32479839 Pygm Rat butanal increases expression ISO PYGM (Homo sapiens) 6480464 butyraldehyde results in increased expression of PYGM mRNA CTD PMID:26079696 Pygm Rat cadmium dichloride increases expression ISO PYGM (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of PYGM mRNA CTD PMID:38568856 Pygm Rat cantharidin decreases expression ISO Pygm (Mus musculus) 6480464 Cantharidin results in decreased expression of PYGM mRNA CTD PMID:36907384 Pygm Rat cisplatin multiple interactions ISO PYGM (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PYGM mRNA CTD PMID:27392435 Pygm Rat cisplatin decreases expression ISO PYGM (Homo sapiens) 6480464 Cisplatin results in decreased expression of PYGM mRNA CTD PMID:27392435 Pygm Rat copper atom increases expression EXP 6480464 Copper results in increased expression of PYGM mRNA CTD PMID:30556269 Pygm Rat copper(0) increases expression EXP 6480464 Copper results in increased expression of PYGM mRNA CTD PMID:30556269 Pygm Rat corosolic acid increases expression ISO PYGM (Homo sapiens) 6480464 corosolic acid results in increased expression of PYGM mRNA CTD PMID:37939859 Pygm Rat daunorubicin decreases expression ISO PYGM (Homo sapiens) 6480464 Daunorubicin results in decreased expression of PYGM mRNA CTD PMID:26537877 and PMID:28940058 Pygm Rat decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of PYGM mRNA CTD PMID:23640034 Pygm Rat decabromodiphenyl ether decreases expression ISO PYGM (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of PYGM protein CTD PMID:31675489 Pygm Rat dexamethasone decreases expression ISO Pygm (Mus musculus) 6480464 Dexamethasone results in decreased expression of PYGM protein CTD PMID:33567340 Pygm Rat disodium selenite decreases expression ISO PYGM (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of PYGM mRNA CTD PMID:18175754 Pygm Rat dorsomorphin multiple interactions ISO PYGM (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PYGM mRNA CTD PMID:27188386 Pygm Rat doxorubicin increases expression ISO Pygm (Mus musculus) 6480464 Doxorubicin results in increased expression of PYGM protein CTD PMID:21251210 Pygm Rat doxorubicin decreases expression ISO PYGM (Homo sapiens) 6480464 Doxorubicin results in decreased expression of PYGM mRNA CTD PMID:26537877 more ... Pygm Rat doxorubicin multiple interactions ISO Pygm (Mus musculus) 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of PYGM protein] CTD PMID:21251210 Pygm Rat endosulfan increases expression ISO PYGM (Homo sapiens) 6480464 Endosulfan results in increased expression of PYGM protein CTD PMID:26615145 Pygm Rat endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PYGM mRNA CTD PMID:29391264 Pygm Rat ethanol increases expression ISO Pygm (Mus musculus) 6480464 Ethanol results in increased expression of PYGM mRNA CTD PMID:30319688 Pygm Rat etoposide decreases expression ISO PYGM (Homo sapiens) 6480464 Etoposide results in decreased expression of PYGM mRNA CTD PMID:29397400 Pygm Rat fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of PYGM mRNA CTD PMID:30307764 Pygm Rat genistein multiple interactions EXP 6480464 [Genistein co-treated with vinclozolin] results in increased expression of PYGM mRNA CTD PMID:23160963 Pygm Rat genistein increases expression EXP 6480464 Genistein results in increased expression of PYGM mRNA CTD PMID:23160963 Pygm Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PYGM mRNA CTD PMID:33387578 Pygm Rat haloperidol decreases expression ISO PYGM (Homo sapiens) 6480464 Haloperidol results in decreased expression of PYGM protein CTD PMID:34122009 Pygm Rat ketamine increases expression EXP 6480464 Ketamine results in increased expression of PYGM mRNA CTD PMID:20080153 Pygm Rat lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of PYGM protein CTD PMID:28916327 Pygm Rat Licochalcone B increases expression ISO PYGM (Homo sapiens) 6480464 licochalcone B results in increased expression of PYGM mRNA CTD PMID:33647349 Pygm Rat mercury dibromide decreases expression ISO PYGM (Homo sapiens) 6480464 mercuric bromide results in decreased expression of PYGM mRNA CTD PMID:26272509 Pygm Rat mercury dibromide multiple interactions ISO PYGM (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PYGM mRNA CTD PMID:27188386 Pygm Rat mitoxantrone decreases expression ISO PYGM (Homo sapiens) 6480464 Mitoxantrone results in decreased expression of PYGM mRNA CTD PMID:26537877 and PMID:28940058 Pygm Rat ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of PYGM mRNA CTD PMID:22124623 Pygm Rat ozone multiple interactions ISO PYGM (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of PYGM mRNA CTD PMID:35430440 Pygm Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PYGM mRNA CTD PMID:32680482 Pygm Rat PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:21673325 Pygm Rat perfluorohexanesulfonic acid decreases expression ISO PYGM (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in decreased expression of PYGM mRNA CTD PMID:25812627 Pygm Rat perfluorononanoic acid decreases expression ISO PYGM (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of PYGM mRNA CTD PMID:25812627 Pygm Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Pygm (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PYGM mRNA CTD PMID:36331819 Pygm Rat perfluorooctane-1-sulfonic acid decreases expression ISO PYGM (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in decreased expression of PYGM mRNA CTD PMID:25812627 Pygm Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PYGM mRNA CTD PMID:35163327 Pygm Rat perfluorooctanoic acid decreases expression ISO PYGM (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of PYGM mRNA CTD PMID:25812627 Pygm Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of PYGM mRNA CTD PMID:35163327 Pygm Rat pioglitazone multiple interactions ISO Pygm (Mus musculus) 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PYGM mRNA CTD PMID:27935865 Pygm Rat potassium chromate increases expression ISO PYGM (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of PYGM mRNA CTD PMID:22079256 Pygm Rat potassium chromate multiple interactions ISO PYGM (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PYGM mRNA CTD PMID:22079256 Pygm Rat prednisone decreases expression ISO PYGM (Homo sapiens) 6480464 Prednisone results in decreased expression of PYGM protein CTD PMID:8815173 Pygm Rat progesterone increases expression EXP 6480464 Progesterone results in increased expression of PYGM mRNA CTD PMID:20726854 Pygm Rat SB 431542 multiple interactions ISO PYGM (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PYGM mRNA CTD PMID:27188386 Pygm Rat silicon dioxide decreases expression ISO PYGM (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of PYGM mRNA CTD PMID:25895662 Pygm Rat silicon dioxide increases expression ISO PYGM (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of PYGM mRNA CTD PMID:23806026 Pygm Rat sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of PYGM protein CTD PMID:29459688 Pygm Rat sodium arsenite increases expression ISO PYGM (Homo sapiens) 6480464 sodium arsenite results in increased expression of PYGM mRNA CTD PMID:38568856 Pygm Rat sodium dichromate increases expression ISO PYGM (Homo sapiens) 6480464 sodium bichromate results in increased expression of PYGM mRNA CTD PMID:17685462 Pygm Rat sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of PYGM protein CTD PMID:29653260 Pygm Rat sodium nitrate multiple interactions ISO Pygm (Mus musculus) 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of PYGM protein] CTD PMID:21251210 Pygm Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of PYGM mRNA CTD PMID:19281266 Pygm Rat streptozocin multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Streptozocin results in decreased activity of PYGM protein] and Polysaccharides inhibits the reaction [Streptozocin results in decreased activity of PYGM protein] CTD PMID:26616445 Pygm Rat streptozocin decreases activity EXP 6480464 Streptozocin results in decreased activity of PYGM protein CTD PMID:26616445 Pygm Rat sunitinib decreases expression ISO PYGM (Homo sapiens) 6480464 Sunitinib results in decreased expression of PYGM mRNA CTD PMID:31533062 Pygm Rat tamoxifen affects expression ISO Pygm (Mus musculus) 6480464 Tamoxifen affects the expression of PYGM mRNA CTD PMID:17555576 Pygm Rat Theaflavin 3,3'-digallate affects expression ISO PYGM (Homo sapiens) 6480464 theaflavin-3 and 3'-digallate affects the expression of PYGM mRNA CTD PMID:34925699 Pygm Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PYGM mRNA CTD PMID:23411599 and PMID:34492290 Pygm Rat thiram increases expression ISO PYGM (Homo sapiens) 6480464 Thiram results in increased expression of PYGM mRNA CTD PMID:38568856 Pygm Rat titanium dioxide increases expression ISO PYGM (Homo sapiens) 6480464 titanium dioxide results in increased expression of PYGM mRNA CTD PMID:34973136 Pygm Rat triphenyl phosphate affects expression ISO PYGM (Homo sapiens) 6480464 triphenyl phosphate affects the expression of PYGM mRNA CTD PMID:37042841 Pygm Rat Triptolide increases expression ISO Pygm (Mus musculus) 6480464 triptolide results in increased expression of PYGM mRNA CTD PMID:32835833 Pygm Rat triptonide increases expression ISO Pygm (Mus musculus) 6480464 triptonide results in increased expression of PYGM mRNA CTD PMID:33045310 Pygm Rat urethane increases expression ISO PYGM (Homo sapiens) 6480464 Urethane results in increased expression of PYGM mRNA CTD PMID:28818685 Pygm Rat valproic acid increases methylation ISO PYGM (Homo sapiens) 6480464 Valproic Acid results in increased methylation of PYGM gene CTD PMID:29154799 Pygm Rat vinclozolin multiple interactions EXP 6480464 [Genistein co-treated with vinclozolin] results in increased expression of PYGM mRNA CTD PMID:23160963 Pygm Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of PYGM mRNA CTD PMID:23160963 Pygm Rat vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PYGM mRNA CTD PMID:19015723 Pygm Rat zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of PYGM mRNA CTD PMID:19111725 Pygm Rat zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of PYGM mRNA CTD PMID:19111725
Imported Annotations - KEGG (archival)
(-)-epigallocatechin 3-gallate (ISO) (R)-noradrenaline (EXP) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP,ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2,4,6-tribromophenol (ISO) 2,5-hexanedione (EXP) 3,3',5,5'-tetrabromobisphenol A (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) acrylamide (EXP) aflatoxin B1 (ISO) alpha-Zearalanol (EXP) ammonium chloride (EXP) aristolochic acid A (ISO) arsenite(3-) (ISO) astemizole (EXP) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) bisphenol F (ISO) bromobenzene (EXP) butanal (ISO) cadmium dichloride (ISO) cantharidin (ISO) cisplatin (ISO) copper atom (EXP) copper(0) (EXP) corosolic acid (ISO) daunorubicin (ISO) decabromodiphenyl ether (EXP,ISO) dexamethasone (ISO) disodium selenite (ISO) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (EXP,ISO) ethanol (ISO) etoposide (ISO) fenvalerate (EXP) genistein (EXP) gentamycin (EXP) haloperidol (ISO) ketamine (EXP) lead diacetate (EXP) Licochalcone B (ISO) mercury dibromide (ISO) mitoxantrone (ISO) ochratoxin A (EXP) ozone (ISO) paraquat (EXP) PCB138 (EXP) perfluorohexanesulfonic acid (ISO) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP,ISO) pioglitazone (ISO) potassium chromate (ISO) prednisone (ISO) progesterone (EXP) SB 431542 (ISO) silicon dioxide (ISO) sodium arsenite (EXP,ISO) sodium dichromate (ISO) sodium fluoride (EXP) sodium nitrate (ISO) Soman (EXP) streptozocin (EXP) sunitinib (ISO) tamoxifen (ISO) Theaflavin 3,3'-digallate (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) triphenyl phosphate (ISO) Triptolide (ISO) triptonide (ISO) urethane (ISO) valproic acid (ISO) vinclozolin (EXP) zinc atom (EXP) zinc(0) (EXP)
1.
Development of potent, orally active 1-substituted-3,4-dihydro-2-quinolone glycogen phosphorylase inhibitors.
Birch AM, etal., Bioorg Med Chem Lett. 2007 Jan 15;17(2):394-9. Epub 2006 Oct 19.
2.
Brain-specific regulator of G-protein signaling 9-2 selectively interacts with alpha-actinin-2 to regulate calcium-dependent inactivation of NMDA receptors.
Bouhamdan M, etal., J Neurosci. 2006 Mar 1;26(9):2522-30.
3.
Structural relationships among regulated and unregulated phosphorylases.
Buchbinder JL, etal., Annu Rev Biophys Biomol Struct. 2001;30:191-209.
4.
Epinephrine regulation of skeletal muscle glycogen metabolism. Studies utilizing the perfused rat hindlimb preparation.
Dietz MR, etal., J Biol Chem. 1980 Mar 25;255(6):2301-7.
5.
Effects of electrostimulation on glycogenolysis in cultured rat myotubes.
Elsner P, etal., Pflugers Arch. 2003 Dec;447(3):356-62. Epub 2003 Oct 25.
6.
Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulation.
Fraser H, etal., Br J Pharmacol. 1999 Sep;128(1):197-205.
7.
Regulation of the rat muscle glycogen phosphorylase-encoding gene during muscle cell development.
Froman BE, etal., Gene 1994 Nov 18;149(2):245-52.
8.
The content of glycogen phosphorylase and glycogen in preparations of sarcoplasmic reticulum-glycogenolytic complex is enhanced in diabetic rat skeletal muscle.
Garduno E, etal., Diabetologia. 2001 Oct;44(10):1238-46.
9.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
10.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
11.
Botulinum-induced muscle paralysis alters metabolic gene expression and fatigue recovery.
Gorin F, etal., Am J Physiol. 1996 Jan;270(1 Pt 2):R238-45.
12.
Comparative analysis of species-independent, isozyme-specific amino-acid substitutions in mammalian muscle, brain and liver glycogen phosphorylases.
Hudson JW, etal., Biochim Biophys Acta 1993 Jul 10;1164(2):197-208.
13.
Adrenaline-mediated glycogen phosphorylase activation is enhanced in rat soleus muscle with increased glycogen content.
Jensen J, etal., Biochim Biophys Acta. 1999 Oct 18;1472(1-2):215-21.
14.
Glycogen phosphorylase: control by phosphorylation and allosteric effectors.
Johnson LN FASEB J. 1992 Mar;6(6):2274-82.
15.
Differential expression of the regulator of G protein signaling RGS9 protein in nociceptive pathways of different age rats.
Kim KJ, etal., Brain Res Dev Brain Res. 2005 Nov 7;160(1):28-39. Epub 2005 Sep 8.
16.
Molecular diagnosis of McArdle disease: revised genomic structure of the myophosphorylase gene and identification of a novel mutation.
Kubisch C, etal., Hum Mutat. 1998;12(1):27-32.
17.
Hepatic and skeletal muscle glycogen metabolism in rats with short-term cholestasis.
Lang C, etal., J Hepatol. 2002 Jan;36(1):22-9.
18.
Skeletal muscle sarcoplasmic reticulum glycogen status influences Ca2+ uptake supported by endogenously synthesized ATP.
Lees SJ and Williams JH, Am J Physiol Cell Physiol. 2004 Jan;286(1):C97-104. Epub 2003 Sep 10.
19.
Gene expression profile of cardiomyocytes in hypertrophic heart induced by continuous norepinephrine infusion in the rats.
Li P, etal., Cell Mol Life Sci. 2003 Oct;60(10):2200-9.
20.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
21.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
22.
Ca2+ uptake coupled to glycogen phosphorolysis in the glycogenolytic-sarcoplasmic reticulum complex from rat skeletal muscle.
Nogues M, etal., Z Naturforsch C. 1996 Jul-Aug;51(7-8):591-8.
23.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
24.
Isolation of partial cDNAs for rat liver and muscle glycogen phosphorylase isozymes.
Osawa S, etal., FEBS Lett 1986 Jul 7;202(2):282-8.
25.
Isozyme pattern of glycogen phosphorylase in the rat nervous system and rat astroglia-rich primary cultures: electrophoretic and polymerase chain reaction studies.
Pfeiffer-Guglielmi B, etal., Neurochem Res. 2000 Nov;25(11):1485-91.
26.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
27.
GOA pipeline
RGD automated data pipeline
28.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
29.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
30.
Glycogen-binding protein components of rat tissues.
Satoh K and Sato K, Biochem Biophys Res Commun. 1980 Sep 16;96(1):28-33.
31.
Electron microscopical study of a cytosolic enzyme in unfixed cryostat sections: demonstration of glycogen phosphorylase activity in rat liver and heart tissue.
Schellens JP, etal., Histochem J. 1995 Aug;27(8):609-14.
32.
Estrogen modulates RGS9 expression in the nucleus accumbens.
Sharifi JL, etal., Neuroreport. 2004 Oct 25;15(15):2433-6.
33.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
34.
Glycogen metabolism in rat heart muscle cultures after hypoxia.
Vigoda A, etal., Mol Cell Biochem. 2003 Dec;254(1-2):311-8.
Pygm (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 1 213,119,805 - 213,134,622 (+) NCBI GRCr8 mRatBN7.2 1 203,690,550 - 203,705,369 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 1 203,690,533 - 203,705,368 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 1 212,039,387 - 212,054,202 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 1 219,135,880 - 219,150,695 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 1 211,826,933 - 211,841,748 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 1 221,756,325 - 221,771,142 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 1 221,756,286 - 221,771,143 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 1 228,737,461 - 228,758,937 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 209,166,701 - 209,181,588 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 1 209,325,179 - 209,340,017 (+) NCBI Celera 1 201,223,967 - 201,238,784 (+) NCBI Celera Cytogenetic Map 1 q43 NCBI
PYGM (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 11 64,746,389 - 64,760,715 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 11 64,746,389 - 64,759,974 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 11 64,513,861 - 64,528,187 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 11 64,270,606 - 64,284,763 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 11 64,270,605 - 64,284,763 NCBI Celera 11 61,840,305 - 61,854,685 (-) NCBI Celera Cytogenetic Map 11 q13.1 NCBI HuRef 11 60,840,630 - 60,855,032 (-) NCBI HuRef CHM1_1 11 64,397,556 - 64,411,957 (-) NCBI CHM1_1 T2T-CHM13v2.0 11 64,739,618 - 64,754,020 (-) NCBI T2T-CHM13v2.0
Pygm (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 19 6,434,438 - 6,448,494 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 19 6,434,429 - 6,448,489 (+) Ensembl GRCm39 Ensembl GRCm38 19 6,384,408 - 6,398,464 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 19 6,384,399 - 6,398,459 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 19 6,384,429 - 6,398,459 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 19 6,384,429 - 6,398,459 (+) NCBI MGSCv36 mm8 Celera 19 6,257,446 - 6,271,476 (+) NCBI Celera Cytogenetic Map 19 A NCBI cM Map 19 4.53 NCBI
Pygm (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955422 20,411,480 - 20,424,931 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955422 20,411,480 - 20,424,676 (+) NCBI ChiLan1.0 ChiLan1.0
PYGM (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 9 65,972,186 - 65,987,376 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 11 67,015,183 - 67,028,876 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 11 60,101,810 - 60,115,813 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 11 63,443,609 - 63,457,012 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 11 63,443,609 - 63,457,430 (-) Ensembl panpan1.1 panPan2
PYGM (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 18 52,398,192 - 52,410,731 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 18 52,398,056 - 52,410,464 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 18 51,005,808 - 51,018,059 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 18 53,439,715 - 53,451,957 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 18 53,439,257 - 53,451,957 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 18 52,534,631 - 52,546,873 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 18 52,120,553 - 52,132,799 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 18 52,904,684 - 52,916,934 (+) NCBI UU_Cfam_GSD_1.0
Pygm (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024404947 8,108,815 - 8,121,764 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936599 4,551,032 - 4,564,154 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936599 4,551,164 - 4,564,109 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
PYGM (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 2 7,409,116 - 7,421,254 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 2 7,409,330 - 7,421,256 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 2 6,540,079 - 6,553,856 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
PYGM (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 1 9,474,539 - 9,490,612 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 1 9,475,622 - 9,491,500 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666038 106,864,368 - 106,879,692 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Pygm (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 163 Count of miRNA genes: 116 Interacting mature miRNAs: 126 Transcripts: ENSRNOT00000028636 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1578778 Pur4 Proteinuria QTL 4 3.3 0.003 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 1 150700247 252085048 Rat 1354646 Kidm18 Kidney mass QTL 18 5.7 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 151162512 256448636 Rat 1357335 Bw39 Body weight QTL 39 3.3 body mass (VT:0001259) body weight (CMO:0000012) 1 197814409 242814409 Rat 1578780 Cm52 Cardiac mass QTL 52 3.3 0.0001 heart mass (VT:0007028) heart wet weight (CMO:0000069) 1 81591954 219808434 Rat 2302375 Bw83 Body weight QTL 83 4.87 0.0002 body mass (VT:0001259) body weight (CMO:0000012) 1 197697768 242697768 Rat 1354652 Kidm20 Kidney mass QTL 20 4.3 kidney mass (VT:0002707) calculated kidney weight (CMO:0000160) 1 177227632 256448636 Rat 2293674 Bss39 Bone structure and strength QTL 39 7.1 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 1 201554356 246554356 Rat 2302378 Insul11 Insulin level QTL 11 3.25 blood insulin amount (VT:0001560) serum insulin level (CMO:0000358) 1 144267353 251128347 Rat 1354653 Despr9 Despair related QTL 9 0.00019 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 1 167909849 212909849 Rat 2293673 Bss27 Bone structure and strength QTL 27 18.63 0.0001 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 1 171629477 216629477 Rat 2293677 Bss41 Bone structure and strength QTL 41 9.38 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 1 171629477 216629477 Rat 1302787 Stl25 Serum triglyceride level QTL 25 2.7 0.0073 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 1 180359209 210702199 Rat 1549830 Bss1 Bone structure and strength QTL 1 4.8 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 1 172609619 217609619 Rat 7794788 Mcs32 Mammary carcinoma susceptibility QTL 32 2.61 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 1 115540693 238914717 Rat 70163 Bw20 Body weight QTL 20 5.1 body mass (VT:0001259) body weight (CMO:0000012) 1 174133260 219133260 Rat 1578763 Kidm29 Kidney mass QTL 29 3.3 0.0001 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 1 179567751 260522016 Rat 1600395 Niddm69 Non-insulin dependent diabetes mellitus QTL 69 4.14 0.0002 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 195804352 257091168 Rat 1354624 Cm35 Cardiac mass QTL35 5.7 heart left ventricle mass (VT:0007031) calculated heart weight (CMO:0000073) 1 177227632 256448636 Rat 1600396 Niddm68 Non-insulin dependent diabetes mellitus QTL 68 4.97 0.0003 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 1558658 Bw59 Body weight QTL 59 3.5 0.0003 body mass (VT:0001259) body weight (CMO:0000012) 1 178784622 223784622 Rat 631838 Niddm36 Non-insulin dependent diabetes mellitus QTL 36 0.01 insulin secretion trait (VT:0003564) calculated pancreatic islet insulin release measurement (CMO:0001217) 1 184550676 229550676 Rat 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 0.05 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 153136852 260522016 Rat 2293689 Bss47 Bone structure and strength QTL 47 7.25 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra trabecular cross-sectional area (CMO:0001692) 1 171629477 216629477 Rat 152025235 Bw194 Body weight QTL 194 4.86 body mass (VT:0001259) 1 123556856 242907031 Rat 1600388 Niddm67 Non-insulin dependent diabetes mellitus QTL 67 5.84 0.000004 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 1 195804352 257091168 Rat 2293694 Bss38 Bone structure and strength QTL 38 7.05 0.0001 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 1 201554356 246554356 Rat 1598853 Memor3 Memory QTL 3 4.5 exploratory behavior trait (VT:0010471) total horizontal distance resulting from voluntary locomotion in an experimental apparatus (CMO:0001443) 1 143506580 212458660 Rat 61341 Bp26 Blood pressure QTL 26 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 169537671 214537671 Rat 1578759 Uae30 Urinary albumin excretion QTL 30 3.3 0.003 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 150700247 252085048 Rat 2293693 Bss22 Bone structure and strength QTL 22 33.52 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 1 171629477 216629477 Rat 2300161 Bmd43 Bone mineral density QTL 43 8.4 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 171629477 216629477 Rat 1300145 Rf7 Renal function QTL 7 2.96 urine creatinine amount (VT:0010540) urine creatinine level (CMO:0000125) 1 185145134 221264292 Rat 8655655 Arrd2 Age-related retinal degeneration QTL 2 7.79 retinal layer morphology trait (VT:0003727) percentage of study population developing retinopathy during a period of time (CMO:0002453) 1 183970203 243914901 Rat 1358898 Bp255 Blood pressure QTL 255 3.6 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 191019702 246062233 Rat 631214 Bw61 Body weight QTL61 3.4 0.0001 intramuscular adipose amount (VT:0010044) intramuscular fat area (CMO:0001162) 1 173108781 218108781 Rat 7771612 Cm80 Cardiac mass QTL 80 8.4 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 1 149448574 221264292 Rat 731168 Bp154 Blood pressure QTL 154 3.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 94642644 214537671 Rat 2300175 Bmd40 Bone mineral density QTL 40 15.4 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 1 201554356 246554356 Rat 2300174 Bmd42 Bone mineral density QTL 42 8.4 0.0001 lumbar vertebra mineral mass (VT:0010511) bone mineral density (CMO:0001226) 1 171629477 216629477 Rat 737828 Hcas3 Hepatocarcinoma susceptibility QTL 3 4.9 liver integrity trait (VT:0010547) liver tumorous lesion volume to total liver volume ratio (CMO:0001082) 1 144267353 222987745 Rat 1354661 Bw33 Body weight QTL 33 5.2 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 1358886 Bp260 Blood pressure QTL 260 3.67 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 151162766 225824951 Rat 737977 Bp160 Blood pressure QTL 160 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 181133855 226133855 Rat 2293654 Bss30 Bone structure and strength QTL 30 32.65 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 1 171629477 216629477 Rat 2293655 Bss36 Bone structure and strength QTL 36 10.66 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 1 201554356 246554356 Rat 1298084 Thym4 Thymus enlargement QTL 4 10.68 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 1 197814409 242814409 Rat 724531 Uae5 Urinary albumin excretion QTL 5 4 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 1 150700142 252085212 Rat 2300187 Bmd41 Bone mineral density QTL 41 8.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 171629477 216629477 Rat 8552891 Epfw5 Epididymal fat weight QTL 5 4.4 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 1 193113876 238113876 Rat 1354580 Scort1 Serum corticosterone level QTL 1 3.4 blood corticosterone amount (VT:0005345) blood corticosterone level (CMO:0001172) 1 156677124 256448636 Rat 1358292 Cm37 Cardiac mass QTL 37 6.2 8e-07 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 1 196248093 241248093 Rat 61376 Bp42 Blood pressure QTL 42 23.4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 197814409 242814409 Rat 634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 199050459 259647894 Rat 634312 Bp143 Blood pressure QTL 143 3 0.0002 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 182623426 219932796 Rat 1358294 Bw37 Body weight QTL 37 5 0.000011 body mass (VT:0001259) body weight (CMO:0000012) 1 171310381 216310381 Rat 724559 Pancm1 Pancreatic morphology QTL 1 7.1 islet of Langerhans morphology trait (VT:0005215) pancreatic islet damage composite score (CMO:0001156) 1 181759564 214537555 Rat 2312420 Pur17 Proteinuria QTL 17 7.1 0.0001 urine protein amount (VT:0005160) urine total protein excretion rate (CMO:0000756) 1 156677124 218753816 Rat 10059600 Bp378 Blood pressure QTL 378 3.08 0.05 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 176869060 221869060 Rat 7421630 Bp362 Blood pressure QTL 362 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 118608292 241799120 Rat 619613 Bp77 Blood pressure QTL 77 0.01 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 164747424 209747424 Rat 2312564 Glom18 Glomerulus QTL 18 2.4 0.003 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 1 185356336 231689108 Rat 634321 Hc1 Hypercalciuria QTL 1 2.91 urine calcium amount (VT:0002985) urine calcium excretion rate (CMO:0000763) 1 178810256 240830002 Rat 2292218 Kidm35 Kidney mass QTL 35 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 199368955 224569684 Rat 724562 Rends1 Renal damage susceptibility QTL 1 0.05 kidney glomerulus integrity trait (VT:0010546) index of glomerular damage (CMO:0001135) 1 169537671 214537671 Rat 1331790 Bp201 Blood pressure QTL 201 3.127 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 198211513 225126682 Rat 10059587 Bw173 Body weight QTL 173 3.23 0.025 body mass (VT:0001259) body weight (CMO:0000012) 1 202069611 247069611 Rat 2292222 Bp307 Blood pressure QTL 307 3.06 0.0014 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 164310393 213533942 Rat 2292220 Bp306 Blood pressure QTL 306 3.47 0.00087 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 164310393 243914901 Rat 10059590 Kidm44 Kidney mass QTL 44 3.42 0.025 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 191033875 236033875 Rat 1641926 Teswt2 Testicular weight QTL 2 2.82 testis mass (VT:1000644) both testes wet weight (CMO:0000175) 1 197697768 238755659 Rat 631658 Cm7 Cardiac mass QTL 7 5.32 0.0001 aorta mass (VT:0002845) aorta weight (CMO:0000076) 1 196248093 241248093 Rat 1600380 Niddm70 Non-insulin dependent diabetes mellitus QTL 70 3.1 0.0008 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 1 176550523 221550523 Rat 1354610 Bw34 Body weight QTL 34 4.1 body mass (VT:0001259) body weight (CMO:0000012) 1 151162512 256448636 Rat 1582206 Kidm33 Kidney mass QTL 33 6.9 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 1 188377360 224054420 Rat 8655855 Arrd3 Age-related retinal degeneration QTL 3 3.07 lens clarity trait (VT:0001304) cataract incidence/prevalence measurement (CMO:0001585) 1 183970203 243914901 Rat 634338 Hcar4 Hepatocarcinoma resistance QTL 4 4.6 liver integrity trait (VT:0010547) liver tumorous lesion number to liver area ratio (CMO:0001210) 1 193422268 214537671 Rat 6903303 Scl34 Serum cholesterol QTL 34 2.5 0.0033 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 1 180359209 218108781 Rat 1600374 Mcs17 Mammary carcinoma susceptibility QTL 17 3 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 1 197670404 242670404 Rat 2293083 Iddm25 Insulin dependent diabetes mellitus QTL 25 4.18 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 181829673 224569684 Rat 1354606 Bp246 Blood pressure QTL 246 3.6 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 102813953 218753816 Rat 738032 Hcas5 Hepatocarcinoma susceptibility QTL 5 3.12 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 176426412 257976495 Rat 1358191 Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 3.8 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 1 192825253 243914732 Rat 7394701 Uae46 Urinary albumin excretion QTL 46 3.6 0.0056 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 1 201554356 246554356 Rat
D1Mgh11
Rat Assembly Chr Position (strand) Source JBrowse RH 3.4 Map 1 1537.2 RGD RH 3.4 Map 1 1537.2 UniSTS FHH x ACI Map 1 98.97 UniSTS FHH x ACI Map 1 98.97 RGD Cytogenetic Map 1 q43 UniSTS
D1Wox28
Rat Assembly Chr Position (strand) Source JBrowse RH 3.4 Map 1 1523.1 UniSTS RH 3.4 Map 1 1523.1 RGD RH 2.0 Map 1 1152.8 RGD Cytogenetic Map 1 q43 UniSTS
RH128350
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 203,705,131 - 203,705,337 (+) MAPPER mRatBN7.2 Rnor_6.0 1 221,770,905 - 221,771,110 NCBI Rnor6.0 Rnor_5.0 1 228,758,694 - 228,758,899 UniSTS Rnor5.0 RGSC_v3.4 1 209,181,351 - 209,181,556 UniSTS RGSC3.4 Celera 1 201,238,547 - 201,238,752 UniSTS RH 3.4 Map 1 1536.3 UniSTS Cytogenetic Map 1 q43 UniSTS
RH140670
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 1 203,696,040 - 203,697,095 (+) MAPPER mRatBN7.2 Rnor_6.0 1 221,761,816 - 221,762,870 NCBI Rnor6.0 Rnor_5.0 1 228,749,605 - 228,750,659 UniSTS Rnor5.0 RGSC_v3.4 1 209,172,192 - 209,173,246 UniSTS RGSC3.4 Celera 1 201,229,458 - 201,230,512 UniSTS RH 3.4 Map 1 1537.7 UniSTS Cytogenetic Map 1 q43 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000028636 ⟹ ENSRNOP00000028636
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 203,690,533 - 203,705,360 (+) Ensembl Rnor_6.0 Ensembl 1 221,756,286 - 221,771,143 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000094854 ⟹ ENSRNOP00000089298
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 203,690,597 - 203,705,368 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000097542 ⟹ ENSRNOP00000085985
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 203,690,533 - 203,705,360 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000099163 ⟹ ENSRNOP00000081606
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 1 203,690,533 - 203,704,922 (+) Ensembl
RefSeq Acc Id:
NM_012638 ⟹ NP_036770
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 1 213,119,805 - 213,134,622 (+) NCBI mRatBN7.2 1 203,690,550 - 203,705,369 (+) NCBI Rnor_6.0 1 221,756,325 - 221,771,142 (+) NCBI Rnor_5.0 1 228,737,461 - 228,758,937 (+) NCBI RGSC_v3.4 1 209,166,701 - 209,181,588 (+) RGD Celera 1 201,223,967 - 201,238,784 (+) RGD
Sequence:
GGCACCGAAGCCATCATCTGCCCTGTTCGGCCCACCCTCCCGCAGCCATGTCCAGGCCTCTTTCAGACCAGGATAAGAGAAAGCAAATCAGTGTTCGTGGCCTAGCTGGCGTGGAAAATGTGTCTGAC CTGAAAAAGAACTTCAACCGCCACCTACATTTCACCCTGGTCAAGGATCGCAATGTGGCCACTCCGAGAGATTACTATTTCGCACTGGCTCACACCGTGCGGGACCACCTCGTGGGACGCTGGATCCG CACACAGCAGCATTACTACGAAAAGGACCCCAAGAGGATCTACTACCTGTCTTTGGAGTTCTACATGGGGAGGACACTGCAGAACACCATGGTGAACCTGGCCTTGGAGAATGCCTGCGATGAGGCCA CCTACCAGCTGGGTCTGGACATGGAGGAGCTGGAGGAGATCGAGGAGGATGCAGGGTTGGGCAATGGAGGCCTGGGACGCCTGGCAGCTTGCTTCCTGGACTCCATGGCTACACTGGGGCTAGCTGCC TATGGCTACGGGATCCGCTATGAGTTTGGGATTTTTAATCAGAAGATCTGTGGGGGCTGGCAGATGGAAGAAGCTGATGACTGGCTTCGCTATGGCAACCCCTGGGAGAAGGCCCGCCCAGAGTTCAC GCTGCCTGTGCACTTCTACGGTCGAGTGGAGCACACCAGTCAGGGTGCCAAGTGGGTGGACACACAGGTAGTGTTGGCTATGCCCTATGACACTCCTGTGCCTGGCTATCGAAACAACGTTGTCAACA CCATGCGCCTCTGGTCGGCCAAGGCACCTAATGACTTCAACCTCAAGGACTTCAACGTTGGCGGCTACATCCAGGCCGTGCTGGACCGAAACCTGGCTGAGAACATCTCACGTGTTTTGTACCCCAAT GATAACTTCTTTGAAGGGAAGGAATTGCGGCTGAAGCAGGAGTACTTTGTGGTGGCCGCCACCCTCCAGGACATCATTCGCCGTTTCAAGTCCTCCAAGTTTGGCTGCCGTGATCCTGTGCGCACAAA CTTTGATGCTTTCCCTGATAAGGTGGCCATCCAGCTCAACGACACCCACCCTTCTTTGGCCATCCCTGAACTGATGAGGATTCTGGTGGACCTGGAACGACTGGACTGGGACAAGGCCTGGGATGTGA CAGTGAAGACCTGTGCCTACACCAACCACACAGTGCTGCCTGAAGCCCTGGAGCGCTGGCCAGTGCACCTCATGGAGACACTGCTTCCCCGCCATCTGCAGATCATTTATGAGATCAACCAGCGTTTC CTTAATCGGGTGGCGGCCGCATTCCCTGGGGACGTAGATAGGCTGCGGCGCATGTCACTCGTGGAGGAAGGAGCGGTGAAACGCATCAACATGGCACACTTGTGCATTGCTGGTTCCCACGCAGTCAA CGGTGTGGCTCGCATCCATTCGGAGATCCTCAAGAAAACCATCTTCAAGGACTTTTATGAGCTGGAGCCTCACAAGTTCCAGAACAAGACCAATGGCATCACCCCTCGGCGCTGGTTGGTTCTGTGTA ACCCTGGGCTGGCAGAGGTCATTGCTGAGCGCATCGGTGAGGAGTACATCTCGGATCTGGACCAGCTACGCAAGCTGCTCTCCTATGTGGATGATGAAGCCTTTATCCGTGATGTGGCCAAAGTGAAA CAGGAAAACAAGTTGAAATTCTCTGCGTACCTGGAGAGGGAATACAAAGTCCACATCAACCCCAACTCCCTCTTCGACGTCCAGGTGAAGAGGATTCATGAGTATAAACGCCAGCTTCTCAATTGCCT TCACATCATCACCTTGTATAACCGCATCAAAAGGGAGCCCAATAGGTTCATGGTGCCAAGGACTATCATGATTGGAGGCAAGGCTGCACCCGGGTACCACATGGCTAAGATGATCATCAAGCTTATCA CCGCCATTGGGGATGTGGTCAACCACGACCCTGCGGTGGGAGACCGCCTCCGAGTGATCTTCCTGGAGAACTACCGAGTCTCACTGGCTGAGAAAGTTATTCCCGCTGCTGACCTCTCAGAGCAGATC TCCACCGCGGGCACTGAGGCCTCAGGCACTGGCAACATGAAGTTCATGCTCAACGGGGCTCTGACCATCGGCACCATGGATGGTGCCAACGTGGAGATGGCAGAGGAGGCTGGGGAAGATAACTTCTT CATCTTCGGCATGCGGGTGGAGGACGTGGAAAGGCTGGACCAGAGAGGGTACAATGCCCAGGAATACTACGACCGGATTCCTGAGCTTCGGCAGATCATCGAACAGTTAAGCAGTGGCTTCTTCTCCC CTAAACAGCCTGACCTGTTCAAGGACATCGTCAACATGCTCATGCACCATGACCGGTTTAAAGTCTTTGCAGATTATGAGGAATACATTAAATGCCAGGACAAAGTCAGTGAGTTGTACAAGAACCCA AGAGAGTGGACACGGATGGTGATCAGGAACATAGCCACCTCTGGCAAGTTTTCCAGTGACCGTACCATTGCCCAGTATGCCCGGGAGATCTGGGGTGTTGAACCTTCTCGTCAGCGCCTGCCAGCCCC AGATGAGAAGATCTGAGCTTCCACACCAGACCCCATACCTGCCTTTGAGTCTGTTTGCAATTCCCGGAATCAGGCCCACTCCAGGGGTTGGGCCCCTGGAATTACATCTCTACCCTCCCCCTTTTGGA AGCCTCTTTTACCAGTCTCTAGGTCCTGATGCCAGTGTGACTAAAGACCCTGCCCTCTTCTTTTCCCTCAACTCCCTACCCCCTTTATTTATGTATGGGGTCTAACCAAGTGCACCCACTCCCCAATA AATCGACTCTCCATGACCTTCCTTAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NP_036770 ⟸ NM_012638
- UniProtKB:
G3V8V3 (UniProtKB/TrEMBL), A6HZH0 (UniProtKB/TrEMBL), B1WBU9 (UniProtKB/TrEMBL)
- Sequence:
MSRPLSDQDKRKQISVRGLAGVENVSDLKKNFNRHLHFTLVKDRNVATPRDYYFALAHTVRDHLVGRWIRTQQHYYEKDPKRIYYLSLEFYMGRTLQNTMVNLALENACDEATYQLGLDMEELEEIEE DAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEFGIFNQKICGGWQMEEADDWLRYGNPWEKARPEFTLPVHFYGRVEHTSQGAKWVDTQVVLAMPYDTPVPGYRNNVVNTMRLWSAKAPNDFNLK DFNVGGYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKSSKFGCRDPVRTNFDAFPDKVAIQLNDTHPSLAIPELMRILVDLERLDWDKAWDVTVKTCAYTNHTVLPEA LERWPVHLMETLLPRHLQIIYEINQRFLNRVAAAFPGDVDRLRRMSLVEEGAVKRINMAHLCIAGSHAVNGVARIHSEILKKTIFKDFYELEPHKFQNKTNGITPRRWLVLCNPGLAEVIAERIGEEY ISDLDQLRKLLSYVDDEAFIRDVAKVKQENKLKFSAYLEREYKVHINPNSLFDVQVKRIHEYKRQLLNCLHIITLYNRIKREPNRFMVPRTIMIGGKAAPGYHMAKMIIKLITAIGDVVNHDPAVGDR LRVIFLENYRVSLAEKVIPAADLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEDNFFIFGMRVEDVERLDQRGYNAQEYYDRIPELRQIIEQLSSGFFSPKQPDLFKDIVNMLMH HDRFKVFADYEEYIKCQDKVSELYKNPREWTRMVIRNIATSGKFSSDRTIAQYAREIWGVEPSRQRLPAPDEKI
hide sequence
Ensembl Acc Id:
ENSRNOP00000028636 ⟸ ENSRNOT00000028636
Ensembl Acc Id:
ENSRNOP00000081606 ⟸ ENSRNOT00000099163
Ensembl Acc Id:
ENSRNOP00000085985 ⟸ ENSRNOT00000097542
Ensembl Acc Id:
ENSRNOP00000089298 ⟸ ENSRNOT00000094854
RGD ID: 13690701
Promoter ID: EPDNEW_R1224
Type: single initiation site
Name: Pygm_1
Description: glycogen phosphorylase, muscle associated
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 1 221,756,235 - 221,756,295 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-11-18
Pygm
glycogen phosphorylase, muscle associated
Pygm
phosphorylase, glycogen, muscle
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2008-10-30
Pygm
phosphorylase, glycogen, muscle
Pygm
muscle glycogen phosphorylase
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2002-06-10
Pygm
Phosphorylase, glycogen; muscle (McArdle syndrome)
Symbol and Name status set to approved
70586
APPROVED